Tyson E. Graber

3.3k total citations
50 papers, 1.7k citations indexed

About

Tyson E. Graber is a scholar working on Molecular Biology, Infectious Diseases and Biomedical Engineering. According to data from OpenAlex, Tyson E. Graber has authored 50 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 17 papers in Infectious Diseases and 10 papers in Biomedical Engineering. Recurrent topics in Tyson E. Graber's work include SARS-CoV-2 detection and testing (16 papers), RNA and protein synthesis mechanisms (11 papers) and RNA Research and Splicing (10 papers). Tyson E. Graber is often cited by papers focused on SARS-CoV-2 detection and testing (16 papers), RNA and protein synthesis mechanisms (11 papers) and RNA Research and Splicing (10 papers). Tyson E. Graber collaborates with scholars based in Canada, United States and United Kingdom. Tyson E. Graber's co-authors include Tommy Alain, Martin Holčı́k, Wayne S. Sossin, Robert Delatolla, Élisabeth Mercier, Patrick M. D’Aoust, Alex MacKenzie, Stephen M. Lewis, Mark R. Servos and Daniel Figeys and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Neuroscience.

In The Last Decade

Tyson E. Graber

47 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tyson E. Graber Canada 22 874 645 355 139 137 50 1.7k
Joep Beumer Netherlands 21 1.2k 1.4× 209 0.3× 416 1.2× 151 1.1× 202 1.5× 30 2.7k
Danilo Licastro Italy 25 1.0k 1.2× 300 0.5× 50 0.1× 127 0.9× 273 2.0× 93 2.3k
José Trevejo United States 18 735 0.8× 157 0.2× 92 0.3× 294 2.1× 112 0.8× 23 1.6k
Kai Dang China 24 709 0.8× 305 0.5× 74 0.2× 44 0.3× 131 1.0× 73 1.6k
Mohamed A. Soliman Egypt 15 690 0.8× 156 0.2× 89 0.3× 218 1.6× 58 0.4× 45 1.2k
Rafael Aldabe Spain 24 785 0.9× 241 0.4× 49 0.1× 487 3.5× 79 0.6× 56 1.8k
Jonathan Bard United States 22 912 1.0× 143 0.2× 41 0.1× 141 1.0× 147 1.1× 61 1.5k
Ceniz Zihni United Kingdom 15 1.0k 1.2× 77 0.1× 101 0.3× 106 0.8× 145 1.1× 19 2.0k
Lifang Song China 12 437 0.5× 231 0.4× 34 0.1× 77 0.6× 64 0.5× 29 847

Countries citing papers authored by Tyson E. Graber

Since Specialization
Citations

This map shows the geographic impact of Tyson E. Graber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyson E. Graber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyson E. Graber more than expected).

Fields of papers citing papers by Tyson E. Graber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tyson E. Graber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyson E. Graber. The network helps show where Tyson E. Graber may publish in the future.

Co-authorship network of co-authors of Tyson E. Graber

This figure shows the co-authorship network connecting the top 25 collaborators of Tyson E. Graber. A scholar is included among the top collaborators of Tyson E. Graber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tyson E. Graber. Tyson E. Graber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kabir, Md Pervez, Élisabeth Mercier, Julio Plaza‐Díaz, et al.. (2025). Diagnostic performance of allele-specific RT-qPCR and genomic sequencing in wastewater-based surveillance of SARS-CoV-2. PubMed. 4(1). 100135–100135. 3 indexed citations
3.
Kabir, Md Pervez, Julio Plaza‐Díaz, Élisabeth Mercier, et al.. (2025). Passive sampling for genomic surveillance of SARS-CoV-2 in wastewater resource recovery facility: Insights for pandemic preparedness. Water Research. 285. 124071–124071.
4.
Graber, Tyson E., et al.. (2024). Puromycin reveals a distinct conformation of neuronal ribosomes. Proceedings of the National Academy of Sciences. 121(7). e2306993121–e2306993121. 2 indexed citations
5.
Mercier, Élisabeth, Patrick M. D’Aoust, Nada Hegazy, et al.. (2024). Sewer transport conditions and their role in the decay of endogenous SARS-CoV-2 and pepper mild mottle virus from source to collection. International Journal of Hygiene and Environmental Health. 263. 114477–114477.
6.
Mercier, Élisabeth, Patrick M. D’Aoust, Md Pervez Kabir, et al.. (2024). Urban wastewater contains a functional human antibody repertoire of mucosal origin. Water Research. 267. 122532–122532. 2 indexed citations
7.
Fuzzen, Meghan, Nivetha Srikanthan, Leslie M. Bragg, et al.. (2023). An improved method for determining frequency of multiple variants of SARS-CoV-2 in wastewater using qPCR assays. The Science of The Total Environment. 881. 163292–163292. 6 indexed citations
8.
Hegazy, Nada, Xin Tian, Patrick M. D’Aoust, et al.. (2023). Impact of coagulation on SARS-CoV-2 and PMMoV viral signal in wastewater solids. Environmental Science and Pollution Research. 31(4). 5242–5253. 1 indexed citations
9.
Hoang, Huy‐Dung, Victoria H. Gilchrist, Xiao Xiang, et al.. (2023). Adaptation of transgene mRNA translation boosts the anticancer efficacy of oncolytic HSV1. Journal for ImmunoTherapy of Cancer. 11(3). e006408–e006408. 2 indexed citations
10.
Nguyen, My-Anh, Huy‐Dung Hoang, Adil Rasheed, et al.. (2022). miR-223 Exerts Translational Control of Proatherogenic Genes in Macrophages. Circulation Research. 131(1). 42–58. 42 indexed citations
11.
Ahmed, Warish, Aaron Bivins, Suzanne Metcalfe, et al.. (2022). RT-qPCR and ATOPlex sequencing for the sensitive detection of SARS-CoV-2 RNA for wastewater surveillance. Water Research. 220. 118621–118621. 21 indexed citations
12.
Wang, Yi, et al.. (2021). The highs and lows of ionizing radiation and its effects on protein synthesis. Cellular Signalling. 89. 110169–110169. 8 indexed citations
13.
Xiang, Xiao, Stéphanie Langlois, Philippe Charron, et al.. (2021). Identification of pannexin 1-regulated genes, interactome, and pathways in rhabdomyosarcoma and its tumor inhibitory interaction with AHNAK. Oncogene. 40(10). 1868–1883. 17 indexed citations
14.
Hoang, Huy‐Dung, Tyson E. Graber, & Tommy Alain. (2018). Battling for Ribosomes: Translational Control at the Forefront of the Antiviral Response. Journal of Molecular Biology. 430(14). 1965–1992. 28 indexed citations
15.
Faye, Mame Daro, Shawn T. Beug, Tyson E. Graber, et al.. (2014). IGF2BP1 controls cell death and drug resistance in rhabdomyosarcomas by regulating translation of cIAP1. Oncogene. 34(12). 1532–1541. 45 indexed citations
16.
Graber, Tyson E., Arkady Khoutorsky, Alexandre David, et al.. (2013). Reactivation of stalled polyribosomes in synaptic plasticity. Proceedings of the National Academy of Sciences. 110(40). 16205–16210. 126 indexed citations
17.
Graber, Tyson E., et al.. (2011). Distinct roles for the cellular inhibitors of apoptosis proteins 1 and 2. Cell Death and Disease. 2(3). e135–e135. 26 indexed citations
18.
Graber, Tyson E., et al.. (2009). NF45 functions as an IRES trans-acting factor that is required for translation of cIAP1 during the unfolded protein response. Cell Death and Differentiation. 17(4). 719–729. 49 indexed citations
19.
Graber, Tyson E. & Martin Holčı́k. (2007). Cap-independent regulation of gene expression in apoptosis. Molecular BioSystems. 3(12). 825–834. 60 indexed citations
20.
Holčı́k, Martin, Tyson E. Graber, Stephen M. Lewis, et al.. (2005). Spurious splicing within the XIAP 5′ UTR occurs in the Rluc/Fluc but not the βgal/CAT bicistronic reporter system. RNA. 11(11). 1605–1609. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026